Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy

By Morales E.   Andres A.   Gonzalez E.   Herrero J.C.   Munoz M.A.   Ortiz M.   Espejo B.   Lumbreras C.   Morales J.M.   Aguado J.M.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 73-74

Elsevier

Access to resources Recommend Favorite

Impact of OKT3 and polyclonal antibodies on symptomatic CMV infection in renal transplant recipients

By Yeung S.   Tong K.L.   Chan H.W.H.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1928-1929

Elsevier

Access to resources Recommend Favorite

Prevalence and Clinical Significance of Antiphospholipid Antibodies in Renal Transplant Recipients

By Ducloux D.   Pellet E.   Chalopin J.M.  

Transplantation Proceedings, Vol. 29, Iss. 5, 1997-08 ,pp. : 2400-2401

Elsevier

Access to resources Recommend Favorite

Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis

By Anglicheau D.   Lautrette A.   Scieux C.   Thervet E.   Martinez F.   Flamant M.   Morinet F.   Legendre C.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2826-2827

Elsevier

Access to resources Recommend Favorite

Utility of the pp65 Direct Antigenemia Test in the Diagnosis of Cytomegalovirus (CMV) in Renal Transplant Recipients

By Sharma A.K.   Taylor J.D.   Tong W.   Brown M.W.   Sells R.A.   Bakran A.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 799-799

Elsevier

Access to resources Recommend Favorite